A new granular data tool shows that vaccination rates for the Measles, Mumps, and Rubella series drop as low as 72 percent in certain Delaware County charter schools, far below the safety threshold. This alarming statistic, unveiled by the Pennsylvania Department of Health, underscores the
Only 34 of the 1,357 AI-enabled devices cleared by the FDA through late 2025 had been included in any form of registered clinical trials during their development. This alarming statistic, recently highlighted in a comprehensive study, suggests that the massive influx of artificial intelligence into
The discrepancy between Embody’s advertised 100% satisfaction guarantee and its formal non-refundable prescription policy presents a critical consideration for prospective patients evaluating the program. As the American healthcare landscape in 2026 continues to struggle with the dual challenges of
The National Institutes of Health recently canceled $15 million in research grants at Emory University and the University of Pittsburgh that were specifically dedicated to studying Alzheimer's disease among Black Americans. This administrative decision has sent shockwaves through the medical
Interpretable mathematical models allow policymakers to see exactly how levers like housing reform or expanded testing impact the trajectory of an outbreak. For decades, the field of epidemiology has frequently treated socio-economic disparities as a passive backdrop to the biological mechanics of
The era of treating computational discovery as a validated shortcut to clinical trials is ending as prospective evidence reveals significant inconsistencies in performance. The biopharmaceutical industry reached a critical juncture in early 2026 when the first large-scale, blinded evaluation of
